Big Gain For Kazia Therapeutics Limited
Fri, Mar 07, 2025 at 07:57 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) soared at $1.18, a gain of 39.6%. On Fri, Mar 07, 2025, KZIA:NASDAQ hit a New 2-Week High of $1.18. The stock got featured on our News Catalysts scanner on Thu, Feb 20, 2025 at 11:59 AM in the 'PRIVATE PLACEMENT' category. From Fri, Feb 21, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Able View Global Inc. (ABLV:NASDAQ), 128.95%
- SUNation Energy Inc Com Par $0.05 (SUNE:NASDAQ), 125.01%
- China Xiangtai Food Co. Ltd. (BTOG:NASDAQ), 121.43%
- Latch Inc. (LTCH:NASDAQ), 56.25%
- Dogwood Therapeutics Inc. (DWTX:NASDAQ), 48.98%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 39.61%
- Alta Global Group Limited (MMA:NYSEMKT), 31.15%
- Willdan Group, Inc. (WLDN:NASDAQ), 29.73%
- Benson Hill Inc. (BHIL:NASDAQ), 28.14%
- ARB IOT Group Limited (ARBB:NASDAQ), 26.14%